Musculoskeletal and Neuropathic Pain in COVID-19

Christopher M. Lam,Miles Sanderson,Dan T. Vu,Dawood Sayed,Usman Latif,Andrea L. Chadwick,Peter Staats,Abigail York,Gabriella Smith,Vivek Velagapudi,Talal W. Khan
DOI: https://doi.org/10.3390/diagnostics14030332
IF: 3.6
2024-02-05
Diagnostics
Abstract:Chronic pain constitutes a significant disease burden globally and accounts for a substantial portion of healthcare spending. The COVID-19 pandemic contributed to an increase in this burden as patients presented with musculoskeletal or neuropathic pain after contracting COVID-19 or had their chronic pain symptoms exacerbated by the virus. This extensive literature review analyzes the epidemiology of pain pre-pandemic, the costs associated with the COVID-19 pandemic, the impact of the virus on the body, mechanisms of pain, management of chronic pain post-pandemic, and potential treatment options available for people living with chronic pain who have had or are currently infected with COVID-19.
medicine, general & internal
What problem does this paper attempt to address?